2 completed, 1 active not recruiting, 1 recruiting. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Active not recruiting 1, Recruiting 1 |
Follow Recurrent Esophageal Squamous Cell Carcinoma: new trials by email Literature Review of Recurrent Esophageal Squamous Cell Carcinoma trials Research Report on Recurrent Esophageal Squamous Cell Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program Home Health Encounter, Nivolumab, Patient Monitoring - Advanced Esophageal Squamous Cell Carcinoma, Advanced Renal Cell Carcinoma | Phase 2 | Recruiting | Mayo Clinic | 50 | 2024-04-30 | 2026-10-02 |
| Study of Docetaxel and Gemcitabine in Metastatic Esophageal Squamous Cell Cancer Gemcitabine/Docetaxel - Metastatic Carcinoma, Recurrent Esophageal Squamous Cell Carcinoma | Phase 2 | Completed | Samsung Medical Center | 24 | 2011-08-01 | 2015-12-29 |
| Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer Cixutumumab, Laboratory Biomarker Analysis, Paclitaxel - Metastatic Esophageal Adenocarcinoma, Metastatic Esophageal Squamous Cell Carcinoma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 94 | 2010-09-21 | 2026-09-10 |
| Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer Laboratory Biomarker Analysis, Oxaliplatin, Pralatrexate - Adenocarcinoma of the Gastroesophageal Junction, Esophageal Undifferentiated Carcinoma | Phase 2 | Completed | Roswell Park Cancer Institute | 35 | 2010-09-01 | 2017-12-13 |
Esophageal Squamous Cell Carcinoma (4) · Adenocarcinoma Of Esophagus (2) · Esophageal Neoplasms (2) · Carcinoma (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Renal Cell (1) · Carcinoma, Transitional Cell (1) · Colorectal Neoplasms (1) · Melanoma (1) · Squamous Cell Carcinoma of Head and Neck (1) · Stomach Neoplasms (1)
Carcinoma, Squamous Cell (4) · Digestive System Diseases (4) · Digestive System Neoplasms (4) · Esophageal Diseases (4) · Gastrointestinal Diseases (4) · Gastrointestinal Neoplasms (4) · Head and Neck Neoplasms (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Neoplasms by Site (4) · Neoplasms, Glandular and Epithelial (4) · Neoplasms, Squamous Cell (4) · Carcinoma (3) · Esophageal Neoplasms (2) · Adenocarcinoma (1)
10-propargyl-10-deazaaminopterin (1) · Docetaxel (1) · Gemcitabine (1) · Home Care Services (1) · House Calls (1) · Nivolumab (1) · Oxaliplatin (1) · Paclitaxel (1) · Remote Patient Monitoring (1) · Taxes (1) · cixutumumab (1)
Mayo Clinic (1) · National Cancer Institute (NCI) (1) · Roswell Park Cancer Institute (1) · Samsung Medical Center (1)
United States (3) · South Korea (1)
Nikhil Khushalani (1) · Roxana S. Dronca, M.D. (1) · Steven J Cohen (1)
P30CA016056 (1), U10CA021115 (1), U10CA180820 (1)